Patients with active acromegaly are at high risk of 25(OH)D deficiency.
Acromegaly is a chronic disease characterized by hypersecretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Electrolyte disturbances such as hypercalcemia and hyperphosphatemia are reported in patients with this disorder. There is limited data on vitamin D status in subjects wit...
Main Authors: | Jowita eHalupczok-Żyła, Aleksandra eJawiarczyk-Przybyłowska, Marek eBolanowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2015.00089/full |
Similar Items
-
Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center
by: Małgorzata Rolla, et al.
Published: (2021-03-01) -
Association of Vitamin D Receptor Polymorphisms With Activity of Acromegaly, Vitamin D Status and Risk of Osteoporotic Fractures in Acromegaly Patients
by: Aleksandra Jawiarczyk-Przybyłowska, et al.
Published: (2019-09-01) -
Obstructive Sleep Apnea Syndrome in Acromegaly Before and After Treatment
by: Selda Korkmaz, et al.
Published: (2014-04-01) -
Prevalence of neoplasms in patients with acromegaly – the need for a national registry
by: Beata Matyjaszek-Matuszek, et al.
Published: (2018-09-01) -
Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
by: Pedro W. Rosario, et al.
Published: (2016-08-01)